vorinostat has been researched along with Thymus Neoplasms in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Thymus Neoplasms: Tumors or cancer of the THYMUS GLAND.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkhaldi, H | 1 |
| Reinhardt, A | 1 |
| Barnett, M | 1 |
| Kundu, S | 1 |
| Hosing, C | 1 |
| Ramdial, J | 1 |
| Saini, N | 1 |
| Srour, S | 1 |
| Alousi, A | 1 |
| Kebriaei, P | 1 |
| Popat, U | 1 |
| Qazilbash, M | 1 |
| Champlin, R | 1 |
| Shpall, EJ | 1 |
| Gulbis, A | 1 |
| Shigle, TL | 1 |
| Dabaja, B | 1 |
| Pinnix, C | 1 |
| Ahmed, S | 1 |
| Steiner, R | 1 |
| Andersson, BS | 1 |
| Nieto, Y | 1 |
1 other study available for vorinostat and Thymus Neoplasms
| Article | Year |
|---|---|
High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Huma | 2023 |